Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
SpaceX IPO Opens to Retail Investors via Major Brokerage Platforms Argus Research Expresses Optimism on Applied Materials LongTerm Prospects Hybrid Manufacturing Gains Traction in Mexico Additive and Machining Converge AI Becoming as Vital as Water and Power Says Singapore Chip Testing Firm Chief as AEM Holdings Shares Surge 450 Cigna Group Downgraded to Hold by Deutsche Bank Amid MultiYear Portfolio Uncertainty CryoPort Inc CYRX Q1 2026 Earnings EPS Falls Short of Expectations as Revenue Details Remain Undisclosed Core Scientific CORZ Q1 2026 Earnings Massive EPS Miss Overshadowed by Positive Stock Reaction ELE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances Alerus Financial Q1 2026 Earnings Significant EPS Beat Fails to Lift Stock as Market Reacts to Uncertain Outlook BlackRock Taxable Municipal Bond Trust BBN Edges Higher as IncomeSeeking Investors Return Borealis Foods BRLS Edges Higher in Quiet Trading Resistance at 153 in Focus Goldman Sachs BDC GSBD Hovers Near Support as Dividend Appeal Offsets Tepid Volume Invesco Value Municipal Income Trust IIM Edges Higher Amid Steady Municipal Bond Demand Microsofts LongTerm Growth Potential Remains Strong Amid Cloud and AI Expansion China Confirms Order for 200 Boeing Jets Signaling Aviation Cooperation with US Treasury Yield Surge Highlights Market Risks and Opportunities for FixedIncome Investors Apples Record Stock Surge Faces Key AI Showcase at Upcoming WWDC AXT Inc Q1 2026 Earnings EPS Surprise Beats Estimates as Company Narrows Loss Essential Utilities Q1 2026 Earnings EPS Falls Short of Estimates Agree Realty Q1 2026 Earnings Modest EPS Beat Amid Stable Operations ClearPoint Neuro Inc CLPT Q1 2026 Earnings EPS Misses Estimates by 1478 Amid Operational Investment METC Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Rises Amid Strategic Updates Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage